Full year results28 Feb 2023 07:49
Croda posted a rise in full-year sales and profit as it hailed a strong performance in Asia, Western Europe and Latin America, and growth across consumer care and life sciences.
In the year to the end of December 2022, pre-tax profit rose 89.6% to £780m, with sales up 10.6% to £2.1bn.
Chief executive Steve Foots said: "2022 has been a milestone year for Croda as we continued our transition to a pure play consumer care and life sciences business, evolving our portfolio to be more closely aligned to the emerging megatrends driving our markets.
"For the first time, we delivered over £2 billion in sales and £500 million in adjusted operating profit, reflecting progress across all areas of our business. Consumer care is increasingly resilient, supported by encouraging growth in our F&F business, whilst life sciences has built on an exceptional prior year, with an exciting project pipeline in pharma and a stand-out performance in crop protection."